고혈압의 진단 및 치료: 2023 유럽고혈압학회 가이드라인을 기반으로

키워드

참고문헌 (74)

1. Kim HC, "Prevalence and management of hypertension in Korean adults", J Korean Med Assoc, 65, pp.633~639 (2022)
2. Thomopoulos C, "Effects of blood-pressurelowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and metaanalyses of randomized trials", J Hypertens, 35, pp.2150~2160 (2017)
3. Kim KI, "Ten-year trends of hypertension treatment and control rate in Korea", Sci Rep, 11, pp.6966~ (2021)
4. Faraco G, "Hypertension : a harbinger of stroke and dementia", Hypertension, 62, pp.810~817 (2013)
5. "2022 KSH guideline: focused update of the 2018 KSH guideline"[URL]
6. Mancia G, "2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension : endorsed by the International Society of Hypertension(ISH)and the European Renal Association(ERA)", J Hypertens, 41, pp.1874~2071 (2023)
7. Ettehad D, "Blood pressure lowering for prevention of cardiovascular disease and death : a systematic review and meta-analysis", Lancet, 387, pp.957~967 (2016)
8. Clark CE, "Association of a difference in systolic blood pressure between arms with vascular disease and mortality : a systematic review and metaanalysis", Lancet, 379, pp.905~914 (2012)
9. Chobanian AV, "Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure", Hypertension, 42, pp.1206~1252 (2003)
10. Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
11. Stergiou GS, "2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement", J Hypertens, 39, pp.1293~1302 (2021)
12. Kallioinen N, "Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings : a systematic review", J Hypertens, 35, pp.421~441 (2017)
13. Stergiou GS, "Cuffless blood pressure measuring devices : review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability", J Hypertens, 40, pp.1449~1460 (2022)
14. "Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34"[URL]
15. Staessen JA, "Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators", JAMA, 282, pp.539~546 (1999)
16. Dolan E, "Superiority of ambulatory over clinic blood pressure measurement in predicting mortality : the Dublin outcome study", Hypertension, 46, pp.156~161 (2005)
17. Ohkubo T, "Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement : a population-based observation in Ohasama, Japan", J Hypertens, 16, pp.971~975 (1998)
18. Niiranen TJ, "Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure : the Finn-Home study", Hypertension, 55, pp.1346~1351 (2010)
19. Stergiou GS, "Home blood pressure monitoring in the diagnosis and treatment of hypertension : a systematic review", Am J Hypertens, 24, pp.123~134 (2011)
20. Park S, "Expert panel consensus recommendations for home blood pressure monitoring in Asia : the HOPE Asia Network", J Hum Hypertens, 32, pp.249~258 (2018)
21. Redon J, "Prognostic value of ambulatory blood pressure monitoring in refractory hypertension : a prospective study", Hypertension, 31, pp.712~718 (1998)
22. Kario K, "Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives : a prospective study", Circulation, 107, pp.1401~1406 (2003)
23. Mancia G, "Long-term prognostic value of blood pressure variability in the general population : results of the Pressioni Arteriose Monitorate e Loro Associazioni Study", Hypertension, 49, pp.1265~1270 (2007)
24. Ntineri A, "Ambulatory versus home blood pressure monitoring : frequency and determinants of blood pressure difference and diagnostic disagreement", J Hypertens, 37, pp.1974~1981 (2019)
25. Palatini P, "Shortterm blood pressure variability outweighs average 24-h blood pressure in the prediction of cardiovascular events in hypertension of the young", J Hypertens, 37, pp.1419~1426 (2019)
26. SCORE2 Working Group, "SCORE2 risk prediction algorithms : new models to estimate 10-year risk of cardiovascular disease in Europe", Eur Heart J, 42, pp.2439~2454 (2021)
27. SCORE2-OP Working Group, "SCORE2-OP risk prediction algorithms : estimating incident cardiovascular event risk in older persons in four geographical risk regions", Eur Heart J, 42, pp.2455~2467 (2021)
28. Lonnebakken MT Izzo R, "Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic(the Campania Salute Network)", J Am Heart Assoc, 6, pp.e004152~ (2017)
29. Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies", Lancet, 360, pp.1903~1913 (2002)
30. Lonn EM, "Blood-pressure lowering in intermediate-risk persons without cardiovascular disease", N Engl J Med, 374, pp.2009~2020 (2016)
31. Zanchetti A, "When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal", J Hypertens, 27, pp.923~934 (2009)
32. Liu L, "The felodipine event reduction(FEVER)study : a randomized longterm placebo-controlled trial in Chinese hypertensive patients", J Hypertens, 23, pp.2157~2172 (2005)
33. Sundstrom J, "Effects of blood pressure reduction in mild hypertension : a systematic review and meta-analysis", Ann Intern Med, 162, pp.184~191 (2015)
34. Arguedas JA, "Blood pressure targets in adults with hypertension", Cochrane Database Syst Rev, 12, pp.CD004349~ (2020)
35. Zhang W, "Trial of intensive blood-pressure control in older patients with hypertension", N Engl J Med, 385, pp.1268~1279 (2021)
36. Beckett NS, "Treatment of hypertension in patients 80 years of age or older", N Engl J Med, 358, pp.1887~1898 (2008)
37. Weber MA, "Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial", Lancet, 363, pp.2049~2051 (2004)
38. Williams B, "2018 ESC", ESH guidelines for the management of arterial hypertension, 2018, pp.39, 3021~3104
39. Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
40. Mancia G, "Reappraisal of European guidelines on hypertension management : a European Society of Hypertension task force document", J Hypertens, 27, pp.2121~2158 (2009)
41. Celik T, "Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients", J Hypertens, 24, pp.591~596 (2006)
42. Shimamoto K, "The Japanese Society of Hypertension guidelines for the management of hypertension(JSH 2014)", Hypertens Res, 37, pp.253~390 (2014)
43. Leenen FH, "Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensinconverting enzyme inhibitor in the antihypertensive and lipidlowering treatment to prevent heart attack trial", Hypertension, 48, pp.374~384 (2006)
44. Williams B, "Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension(PATHWAY-2) : a randomised, double-blind, crossover trial", Lancet, 386, pp.2059~2068 (2015)
45. Chua SK, "The antihypertensive effects and safety of LCZ696 in patients with hypertension : a systemic review and meta-analysis of randomized controlled trials", J Clin Med, 10, pp.2824~ (2021)
46. Roush GC, "Head-tohead comparisons of hydrochlorothiazide with indapamide and chlorthalidone : antihypertensive and metabolic effects", Hypertension, 65, pp.1041~1046 (2015)
47. Ishani A, "Chlorthalidone vs. hydrochlorothiazide for hypertension-cardiovascular events", N Engl J Med, 387, pp.2401~2410 (2022)
48. Roush GC, "Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events : systematic review and network meta-analyses", Hypertension, 59, pp.1110~1117 (2012)
49. Wajngarten M, "Hypertension and stroke : update on treatment", Eur Cardiol, 14, pp.111~115 (2019)
50. Willey JZ, "Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study", J Am Heart Assoc, 3, pp.e001106~ (2014)
51. Moullaali TJ, "Blood pressure control and clinical outcomes in acute intracerebral haemorrhage : a preplanned pooled analysis of individual participant data", Lancet Neurol, 18, pp.857~864 (2019)
52. Rodriguez-Luna D, "Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage", Eur J Neurol, 20, pp.1277~1283 (2013)
53. Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2015, pp.46, 2032~2060
54. Buletko AB, "Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage", Neurology, 91, pp.e1058~e1066 (2018)
55. Wang X, "J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage : a pooled analysis of INTERACT2and ATACH-II individual participant data", Int J Stroke, 17, pp.1129~1136 (2022)
56. Moullaali TJ, "Early lowering of blood pressure after acute intracerebral haemorrhage : a systematic review and meta-analysis of individual patient data", J Neurol Neurosurg Psychiatry, 93, pp.6~13 (2022)
57. Qureshi AI, "Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure : post hoc analysis of a randomized clinical trial", JAMA Neurol, 77, pp.1355~1365 (2020)
58. Tsivgoulis G, "Intensive blood pressure reduction in acute intracerebral hemorrhage : a meta-analysis", Neurology, 83, pp.1523~1529 (2014)
59. Britton M, "Blood pressure course in patients with acute stroke and matched controls", Stroke, 17, pp.861~864 (1986)
60. Powers WJ, "2018 guidelines for the early management of patients with acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2018, pp.49, e46~e110
61. Ahmed N, "Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis : retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register(SITS-ISTR)", Stroke, 40, pp.2442~2449 (2009)
62. Wu W, "Relationship between blood pressure and outcomes in acute ischemic stroke patients administered lytic medication in the TIMS-China study", PLoS One, 11, pp.e0144260~ (2016)
63. Robinson TG, "Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study(COSSACS) : a prospective, randomised, open, blinded-endpoint trial", Lancet Neurol, 9, pp.767~775 (2010)
64. Progress Collaborative Group, "Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack", Lancet, 358, pp.1033~1041 (2001)
65. Pats Collaborating Group, "Post-stroke antihypertensive treatment study. A preliminary result", Chin Med J (Engl), 108, pp.710~717 (1995)
66. Lawes CM, "Blood pressure and stroke : an overview of published reviews", Stroke, 35, pp.776~785 (2004)
67. Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2014, pp.45, 2160~2236
68. Group SPSS, "Blood-pressure targets in patients with recent lacunar stroke : the SPS3 randomised trial", Lancet, 382, pp.507~515 (2013)
69. Siedlinski M, "Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure", Eur Heart J, 44, pp.2114~2125 (2023)
70. Collaborators GBDD, "Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016 : a systematic analysis for the global burden of disease study 2016", Lancet Neurol, 18, pp.88~106 (2019)
71. Collaborators GBDDF, "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050 : an analysis for the global burden of disease study 2019", Lancet Public Health, 7, pp.e105~e125 (2022)
72. Peters R, "Blood pressure lowering and prevention of dementia : an individual patient data meta-analysis", Eur Heart J, 43, pp.4980~4990 (2022)
73. Godin O, "Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes : the threecity(3C)-Dijon magnetic resonance imaging study", Circulation, 123, pp.266~273 (2011)
74. Verhaaren BF, "High blood pressure and cerebral white matter lesion progression in the general population", Hypertension, 61, pp.1354~1359 (2013)

관련 논문AI추천